Category: conjugate
-
Q&A Spotlight with Andrew Young, CEO of Conjugate Group
•
Andrew Young is an influential leader in the biotechnology sector, serving as CEO and Managing Partner of Conjugate Group, a renowned staffing and business development firm in Wellesley, Massachusetts. Born in July 1970, Andrew’s career has been marked by a deep commitment to bridging talent gaps in the biopharmaceutical industry,…
-
Merck, Kelun buoyed by phase 3 results for breast cancer antibody drug conjugate
•
JHVEPhoto/iStock Editorial via Getty Images Merc (New York Stock Exchange: Merck) and its Sichuan partner Kelun-Biotech reported that phase III data on its antibody drug candidate Sacituzumab tirumotecan (sac-TMT) led to a 69% reduction in the risk of progression or death in people with triple-negative breast cancer. From 233 Of…